blindspotbio: research&bioinformatics as a service – Medium

blindspotbio: research&bioinformatics as a service

Pinned

Tour de force proteomics dataset reveals new clues to small molecule mechanism of action (MOA) and…

A new study used proteomics to decipher the mechanisms of action of 875 drugs, providing a valuable resource for understanding how drugs…

Oct 17, 2023

2D chemical structures of six poly(ADP-ribose) polymerase (PARP) inhibitors used in this study. Top row include three FDA approved compounds (olaparib, rucaparib, and talazoparib), bottom row include three investigational compounds (PJ34, veliparib, and XAV939)

Oct 17, 2023

Pinned

Cancer Microbiome Reanalysis

A bioXriv preprint contends that a 2020 paper linking bacteria to cancer was based on flawed data analysis

Aug 29, 2023

Colorized scanning electron micrograph of spherical Group A Streptococcus (Streptococcus pyogenes) bacteria and a human neutrophil. Credit: NIAID

Aug 29, 2023

2023Q1 FDA Drug Approvals

13 drugs were approved by the FDA in the first quarter of 2023; 4 of them for rare diseases, 3 for cancers.

May 25, 2023

2023Q1 FDA Drug Approvals

May 25, 2023

blindspotbio: research&bioinformatics as a service

blindspotbio: research&bioinformatics as a service

Highlighting publicly available datasets and blind spots found in omics data analysis. Visit https://blindspotbio.com for research & bioinformatics services.

Following

Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams